Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension | Digestive Diseases and Sciences
Fibrosis: Development
Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience
Transient elastography assessed hepatic steatosis and fibrosis are associated with body composition in the United States | medRxiv
NON-OBESE NAFLD IS ASSOCIATED WITH HIGHER SCD14 CONCENTRATIONS IN ADULTS WITH HIV
COMPARISON OF THE BASELINE CHARACTERISTICS OF PATIENTS WITH CAP < 220... | Download Table
Controlled Attenuation Parameter (CAP) and liver stiffness cut-offs... | Download Scientific Diagram
Table 1 from The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. | Semantic Scholar
Fibroscan™ (Sound Based Elastography) | Gastro Health - Framingham
![PDF] Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/aeff7274892fbe6500c35da9cc35da059a5956a8/4-Table2-1.png "PDF] Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease | Semantic Scholar")
PDF] Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease | Semantic Scholar
Fibroscan.dr quiyum | PPT
SciELO - Brasil - MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY MEASUREMENT OF
Fibroscan - Dr Douglas Samuel
Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard | BMC Pediatrics | Full Text
Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease - Nan Xu, Qinxiu Xie, Jiang Li, Yufeng Gao, Xu
Fibroscan™ (Sound Based Elastography) | Gastro Health - Framingham
Fibroscan - Dr Douglas Samuel
Frontiers | Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement
Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and 1H-MR Spectroscopy | PLOS ONE
Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample - Nagaoki - 2022 - Hepatology Research - Wiley Online Library
My FibroScan Experience and Test Results
Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis
Changes in CAP (dB/m) and weight (Kg) in the overall population (A, B). | Download Scientific Diagram
Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery | Scientific Reports
